An investigation for investors in NASDAQ:LOXO shares was announced over potential breaches of fiduciary duties by certain Loxo Oncology directors.
Investors who purchased shares of Loxo Oncology Inc (NASDAQ:LOXO) and currently hold any of those NASDAQ:LOXO shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Loxo Oncology Inc directors breached their fiduciary duties and caused damage to the company and its shareholders.
Stamford, CT based Loxo Oncology, Inc. is a United States-based biopharmaceutical company that is engaged in developing selective medicines for patients with genetically defined cancers.
Loxo Oncology Inc went public in August 2014 and shares of Loxo Oncology Inc (NASDAQ:LOXO) reached as high as $44.95 per share.
On February 23, 2017, NASDAQ:LOXO shares closed at $42.24 per share.
Those who purchased NASDAQ:LOXO shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego